Doherty RR - Search Results

1

The efficacy and safety of zidovudine with or without acyclovir in the treatment of patients with AIDS-related complex. The European-Australian Collaborative Group.

Cooper DA, Pedersen C, Aiuti F, Vilde JL, Ruhnke M, Pehrson PO, Clumeck N, Farthing C, Lüthy R, Doherty RR, et al. Cooper DA, et al. Among authors: doherty rr. AIDS. 1991 Aug;5(8):933-43. doi: 10.1097/00002030-199108000-00003. AIDS. 1991. PMID: 1777174 Clinical Trial.

2

The effect of treatment with zidovudine with or without acyclovir on HIV p24 antigenaemia in patients with AIDS or AIDS-related complex.

Pedersen C, Cooper DA, Brun-Vézinet F, Doherty R, Skinhøj P, Pérol Y, Lüthy R, Leibowitch J, Habermehl KO, Varnier OE, et al. Pedersen C, et al. AIDS. 1992 Aug;6(8):821-5. doi: 10.1097/00002030-199208000-00009. AIDS. 1992. PMID: 1418778 Clinical Trial.

3

CD8+ T-cells from HIV-infected patients can either augment or abrogate HIV-specific lymphoproliferation.

Bell SJ, Cooper DA, Kemp BE, Doherty RR, Penny R. Bell SJ, et al. Among authors: doherty rr. Clin Immunol Immunopathol. 1992 Sep;64(3):254-60. doi: 10.1016/0090-1229(92)90208-6. Clin Immunol Immunopathol. 1992. PMID: 1643759

4

Definition of an immunodominant T cell epitope contained in the envelope gp41 sequence of HIV-1.

Bell SJ, Cooper DA, Kemp BE, Doherty RR, Penny R. Bell SJ, et al. Among authors: doherty rr. Clin Exp Immunol. 1992 Jan;87(1):37-45. doi: 10.1111/j.1365-2249.1992.tb06410.x. Clin Exp Immunol. 1992. PMID: 1370773 Free PMC article.

5

Heterogeneous effects of exogenous IL-2 on HIV-specific cell-mediated immunity (CMI).

Bell SJ, Cooper DA, Kemp BE, Doherty RR, Penny R. Bell SJ, et al. Among authors: doherty rr. Clin Exp Immunol. 1992 Oct;90(1):6-12. doi: 10.1111/j.1365-2249.1992.tb05823.x. Clin Exp Immunol. 1992. PMID: 1395102 Free PMC article.

6

Decreased in vitro susceptibility to zidovudine of HIV isolates obtained from patients with AIDS.

Land S, Terloar G, McPhee D, Birch C, Doherty R, Cooper D, Gust I. Land S, et al. J Infect Dis. 1990 Feb;161(2):326-9. doi: 10.1093/infdis/161.2.326. J Infect Dis. 1990. PMID: 2299212

7

Use of a conserved immunodominant epitope of HIV surface glycoprotein gp41 in the detection of early antibodies.

Cumming SA, McPhee DA, Maskill WJ, Kemp BE, Doherty RR, Gust ID. Cumming SA, et al. Among authors: doherty rr. AIDS. 1990 Jan;4(1):83-6. doi: 10.1097/00002030-199001000-00012. AIDS. 1990. PMID: 1690552

8

Clinical effects and in vitro studies of trifluorothymidine combined with interferon-alpha for treatment of drug-resistant and -sensitive herpes simplex virus infections.

Birch CJ, Tyssen DP, Tachedjian G, Doherty R, Hayes K, Mijch A, Lucas CR. Birch CJ, et al. J Infect Dis. 1992 Jul;166(1):108-12. doi: 10.1093/infdis/166.1.108. J Infect Dis. 1992. PMID: 1318909

9

Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir and foscarnet resistant herpes simplex viruses infecting an immunocompromised patient.

Chibo D, Mijch A, Doherty R, Birch C. Chibo D, et al. J Clin Virol. 2002 Aug;25(2):165-70. doi: 10.1016/s1386-6532(02)00005-7. J Clin Virol. 2002. PMID: 12367650

10

Post-treatment control in an adult with perinatally acquired HIV following cessation of antiretroviral therapy.

McMahon JH, Chang J, Tennakoon S, Dantanarayana A, Solomon A, Cherry C, Doherty R, Cameron P, Lewin SR. McMahon JH, et al. AIDS. 2017 Jun 1;31(9):1344-1346. doi: 10.1097/QAD.0000000000001472. AIDS. 2017. PMID: 28492397 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

47 results

Search Page

Filters